Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats

Synapse

Volumn 64, Issue 2, 2010, Pages 172-176

  Itoh, Tetsuji ^a,b   Abe, Kohji ^a,b,c   Hong, Jinsoo ^a   Inoue, Osamu ^c   Pike, Victor W ^a   Innis, Robert B ^a   Fujita, Masahiro ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b SHIONOGI AND CO LTD   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3',5' PHOSPHOROTHIOATE; BUCLADESINE; PHOSPHODIESTERASE IV; RADIOPHARMACEUTICAL AGENT; ROLIPRAM CARBON 11; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG EFFECT; DRUG PROTEIN BINDING; ENANTIOMER; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EVOKED RESPONSE; IN VIVO STUDY; MALE; NEUROMODULATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

ANIMALS; BRAIN; BUCLADESINE; CARBON RADIOISOTOPES; CENTRAL NERVOUS SYSTEM AGENTS; CEREBROVASCULAR CIRCULATION; CONSCIOUSNESS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; MALE; PHOSPHODIESTERASE INHIBITORS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; ROLIPRAM; THIONUCLEOTIDES;

EID: 72449172000     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20728     Document Type: Article

References (14)

1. 11C]rolipram and positron emission tomography. Eur J Nucl Med Mol Imaging 29:1680-1683.
2. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
3. 11C]rolipram-PET. NeuroImage 26:1201-1210.
4. Harada N, Nishiyama S, Ohba H, Sato K, Kakiuchi T, Tsukada H. 2002. Age differences in phosphodiesterase type-IV and its functional response to dopamine D1 receptor modulation in the living brain: A PET study in conscious monkeys. Synapse 44:139-145. (Pubitemid 34303911)
5. Hoffmann R, Wilkinson IR, McCallum JF, Engels P, Houslay MD. 1998. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model. Biochem J 333(Part 1):139-149. (Pubitemid 28342503)
6. 14C]-2-deoxyglucose uptake in freely moving rats. Brain Res 921:260-263.
7. Hosoi R, Matsumura A, Mizokawa S, Tanaka M, Nakamura F, Kobayashi K, Watanabe Y, Inoue O. 2005. MicroPET detection of enhanced 18F-FDG utilization by PKA inhibitor in awake rat brain. Brain Res 1039:199-202. (Pubitemid 40386843)
8. 11C-(R)-rolipram and the density of its target, phosphodiesterase-4, in brain of conscious and anesthetized rats. J Nucl Med 50:749-756.
9. 11C]rolipram in rat brain, lung and heart. Life Sci 79:356-364.
10. 11C]rolipram in man. J Cereb Blood Flow Metab 23(S):678.
11. Nestler EJ, Aghajanian GK. 1997. Molecular and cellular basis of addiction. Science 278:58-63.
12. 11C]methylspiperone binding in vivo: Positron emission tomography study using conscious rhesus monkey. Brain Res 663:191-198.
13. Seidel J, Vaquero JJ, Green MV. 2003. Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: Comparison to simulated LSO scanners without depth-of-interaction capability. IEEE Trans Nucl Sci 50:1347-1350.
14. 1 receptors: PET studies in the conscious monkey brain. Synapse 42:258-265.